BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9518260)

  • 1. Thiol redox modulation of tumor necrosis factor-alpha responsiveness in cultured AIDS-related Kaposi's sarcoma cells.
    Mallery SR; Landwehr DJ; Ness GM; Clark YM; Hohl CM
    J Cell Biochem; 1998 Mar; 68(3):339-54. PubMed ID: 9518260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
    Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
    J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiol redox modulation of doxorubicin mediated cytotoxicity in cultured AIDS-related Kaposi's sarcoma cells.
    Mallery SR; Clark YM; Ness GM; Minshawi OM; Pei P; Hohl CM
    J Cell Biochem; 1999 May; 73(2):259-77. PubMed ID: 10227389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultured AIDS-related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities.
    Mallery SR; Ng-Bautista CL; Lantry LE; Ness GM; Hegtvedt AK; Lazo A; Bailer RT; Hout BL; Stephens RE; Brierley GP
    J Cell Biochem; 1994 Dec; 56(4):568-81. PubMed ID: 7890815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma.
    Mallery SR; Pei P; Landwehr DJ; Clark CM; Bradburn JE; Ness GM; Robertson FM
    Carcinogenesis; 2004 Apr; 25(4):597-603. PubMed ID: 14656937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
    Murakami-Mori K; Mori S; Bonavida B; Nakamura S
    J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
    Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
    J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
    Murakami-Mori K; Mori S; Nakamura S
    J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
    Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
    Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
    Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B
    J Immunol; 1999 May; 162(9):5616-23. PubMed ID: 10228045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
    Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B
    Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
    Samaniego F; Markham PD; Gallo RC; Ensoli B
    J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
    Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
    J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation.
    Guo WX; Gill PS; Antakly T
    Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.
    Guo WX; Antakly T; Cadotte M; Kachra Z; Kunkel L; Masood R; Gill P
    Am J Pathol; 1996 Jun; 148(6):1999-2008. PubMed ID: 8669484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
    Dictor M; Rambech E; Way D; Witte M; Bendsöe N
    Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
    Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
    Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of IL-6, IL-10 and CXCL10 serum concentrations with visceral Kaposi's sarcoma in people living with HIV/AIDS.
    Lopes TRR; Gonçales JP; Silva Júnior JVJ; Lorena VMB; Toscano ALCC; Akamatsu SM; Salles AC; Tozetto-Mendoza TR; Morais VMS; Coêlho MRCD
    Hum Immunol; 2020 Jan; 81(1):26-31. PubMed ID: 31866063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.